Through clarifying the expression and clinical significance of CRABP2 in ESCC, we aim to explore the biological function of CRABP2, the relationship between CRABP2 and its closely related proteins FABP5, and provide new clues for molecular targeted therapy of ESCC. This evidence concerns the gene CRABP2 and esophageal squamous cell carcinoma.